Department: Senior Leadership

Brian Piper is Chief Financial Officer of Sana Biotechnology. Prior to joining Sana, Mr. Piper served as Chief Financial Officer of Scorpion Therapeutics until its acquisition by Eli Lilly in 2025, and thereafter was Chief Financial Officer of Antares Therapeutics, following its spin-off from Scorpion. Previously, he was Chief Financial Officer of Prelude Therapeutics, where […]

Yuko Soneoka, PhD, JD, is Senior Vice President and Head of Intellectual Property. Prior to joining Sana, Yuko was Vice President of Intellectual Property at Ring Therapeutics, a Flagship Pioneering company. Over a 25 year career in patent law, she has served as in-house counsel at various biotechnology companies as well as outside counsel at […]

Debra Wisdom is the Vice President, Head of People at Sana Biotechnology. Debra previously served as Executive Director, Senior People Leader at Sana, where she was responsible for building an integrated organization to support the R&D functions. As a strategic business partner, she has successfully onboarded and coached C-Suite leaders, from academia to industry, while […]

Susan Wyrick is Senior Vice President, Finance and Accounting and Acting Chief Financial Officer at Sana Biotechnology. Prior to Sana, Susan served as Vice President, Controller at Juno Therapeutics, where she led the global accounting organization. During her time at Juno, she was a key contributor to the company’s successful IPO, which raised over $300M. […]